期刊文献+

参芪扶正注射液对人鼻咽癌CNE-2细胞生长抑制的体外实验 被引量:1

Inhibiting effect of Shenqifuzheng injection on human nasopharyngeal carcinoma CNE-2 cells in vitro
在线阅读 下载PDF
导出
摘要 目的观察参芪扶正注射液对人鼻咽癌CNE-2细胞的生长抑制作用,为其临床应用提供理论依据。方法将不同浓度的参芪扶正注射液与CNE-2细胞作用24、48、72和96h,用MTT法检测参芪扶正注射液对CNE-2细胞的生长抑制率,流式细胞仪分析细胞周期的变化、检测细胞凋亡率,荧光显微镜观察细胞形态学变化。结果参芪扶正注射液对CNE-2细胞的生长抑制率随药物浓度和作用时间的增加而增大。流式细胞仪分析显示参芪扶正注射液将CNE-2细胞明显阻滞于G1期。参芪扶正注射液浓度为8.0g/L作用48h,CNE-2细胞的凋亡率为39.3%,荧光显微镜下观察有凋亡细胞存在。结论参芪扶正注射液能够抑制人鼻咽癌CNE-2细胞的增殖,能使CNE-2细胞阻滞于G1期,可诱导CNE-2细胞发生一定程度的凋亡。 【Objective】To study the inhibiting effects of Shenqifuzheng injection on human nasopharyngeal car-cinoma CNE-2 cells. 【Methods】CNE-2 cells were incubated with Shenqifuzheng injection at various concentra-tions and time,cell growth inhibition was assessed by MTT assay,cell-cycle kinetics and apoptosis were analyzed by fluorenscence microscopy and flow cytometry. 【Results】The growth of CNE-2 cells was significantly inhibited by Shenqifuzheng injection in dose-dependent and time-dependent fashion. Analysis of flow cytometry showed that Shenqifuzheng injection could cause CNE-2 cell cycle to change and block CNE-2 cells in G1 phase. The apoptosis rate of CNE-2 cells was 39.3% after incubation with 8 g/L Shenqifuzheng injection for 48 hours. The apoptotic cells were observed under the fluorescence microscope. 【Conclusion】Shenqifuzheng injection suppresses the growth of CNE-2 cells in vitro by causing cell-cycle arrest and cell apoptosis.
出处 《中国医学工程》 2008年第4期269-271,274,共4页 China Medical Engineering
关键词 参芪扶正注射液 鼻咽癌 凋亡 Shenqifuzheng injection nasopharyngeal carcinoma apoptosis
  • 相关文献

参考文献1

二级参考文献8

  • 1岳琴.紫杉醇及其相关化合物的研究进展[J].国外医学(药学分册),1996,23(6):327-334. 被引量:4
  • 2Westerlund A, Hujanen E, Hoyhtya M, et al. Overian cancer cell invasion is inhibited by paclitasel[J]. Clin Exp metastasis, 1997, 15(3): 318-328.
  • 3Wang TH, Wang HS, Soong YK. Paclitaxelinduced cell death: where the cell cycle and apoptosis come together[J]. Cancer, 2000, 88(11): 2619-2919.
  • 4Hussain M, Gadgeel S, Kucuk O, et al. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck[J]. Cancer, 1999, 86(6): 2364-2469.
  • 5Trudeau ME. Phase I-II Studies of docetaxel as a single agent in the treatment of metastatic breast cancer[J]. Semin Oncol, 1999, 26(3): 21-26.
  • 6Rowinsky EK. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents[J]. Annu Rev Med, 1997, 48(5): 353-374.
  • 7Bacus SS. Gudkou AV, Lowe M, et al. Taxol-induced apoptosis depends on MAP Kinase pathways (ERK and P38) and is independent of p53[J]. Oncogene, 2001, 20(2): 147-155.
  • 8王承龙,赖金平,唐发清,肖健云,田勇泉,邓波,罗均利.HNE1细胞株光动力学治疗前后形态学的动态变化[J].中国耳鼻咽喉颅底外科杂志,2000,6(1):32-35. 被引量:9

共引文献7

同被引文献16

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部